Cargando…
Height outcomes in children with growth hormone deficiency and idiopathic short stature treated concomitantly with growth hormone and aromatase inhibitor therapy: data from the ANSWER program
BACKGROUND: Treatment of children with growth hormone deficiency (GHD) or idiopathic short stature (ISS) using GH is only effective for bone growth prior to epiphyseal fusion. Aromatase inhibitor therapy (AIT) blocks estrogen production, thereby delaying epiphyseal fusion. The current study analyzed...
Autores principales: | Miller, Bradley S., Ross, Judith, Ostrow, Vlady |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537098/ https://www.ncbi.nlm.nih.gov/pubmed/33042202 http://dx.doi.org/10.1186/s13633-020-00089-z |
Ejemplares similares
-
Comparison of Growth Hormone Treatment in Patients with Idiopathic Short Stature and Idiopathic Growth Hormone Deficiency
por: Kim, Seul Ah, et al.
Publicado: (2014) -
Effect of growth hormone treatment on children with idiopathic short stature and idiopathic growth hormone deficiency
por: Im, Minji, et al.
Publicado: (2017) -
Isolated Growth Hormone Deficiency and Idiopathic Short Stature: Comparative Efficiency after Growth Hormone Treatment up to Adult Height
por: Ariza-Jimenez, Ana-Belen, et al.
Publicado: (2021) -
Differences in Response to Recombinant Growth Hormone Therapy on Height Gain in Patients with Idiopathic Short Stature Vs. Patients with Growth Hormone Deficiency
por: Alzahrani, Ali K, et al.
Publicado: (2020) -
Response to growth hormone according to provocation test results in idiopathic short stature and idiopathic growth hormone deficiency
por: Yoon, Ju Young, et al.
Publicado: (2022)